Mascoma Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5
Closed -$682 – 642
2026
Q2
$682 Buy
+5
New +$614 ﹤0.01% 535
2019
Q3
– Sell
-700
Closed -$60K – 279
2019
Q2
$60K Hold
700
– – 0.04% 149
2019
Q1
$41K Buy
+700
New +$40.3K 0.03% 164

Other funds holding RGEN

Mascoma Wealth Management's RGEN Position: Q3 2026 in Review

Mascoma Wealth Management sold out of Repligen (RGEN) in Q3 2026, closing a stake of 5 shares — an estimated $682 sold.

Mascoma Wealth Management first reported a position in RGEN in Q1 2019 and held it in 3 quarters. The position peaked at $60K in Q2 2019. 85 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Mascoma Wealth Management reported no remaining Repligen position as of Q3 2026 after selling out during the quarter.
  • Mascoma Wealth Management sold 5 Repligen shares in Q3 2026, an estimated $682.
  • Mascoma Wealth Management first reported a position in Repligen in Q1 2019 and held it in 3 quarters.
  • Mascoma Wealth Management's Repligen position peaked at $60K in Q2 2019.
  • 85 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Mascoma Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.